Close
Novotech

News

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Charles River Laboratories International, Inc. and the INADcure Foundation, a nonprofit organization whose mission is to support the development of treatments for Infantile Neuroaxonal Dystrophy (INAD) and other forms of PLA2G6-related neurodegeneration (PLAN), today announced a plasmid DNA manufacturing...

Quell Therapeutics, AstraZeneca Partner on Engineered Treg Cell Therapies

Quell Therapeutics Ltd, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced that it has entered into a collaboration, exclusive option and license agreement with AstraZeneca to develop, manufacture...

Pharma Dealmaking Recovery Gets Boosted By $85bn M&A Splurge

It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which itself went on to mark a dramatic recovery when it comes to dealmaking as they...

Lack of Experience Hinders CDMOs In Cell And Gene Therapy

CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy manufacturing for Phase III trials and commercialization. While physical capacity has been blamed, the...

Corning and SGD Pharma announce joint venture to open new glass tubing facility and expand access to Corning Velocity Vial technology in India

ย Corningย Incorporated and SGD Pharma announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing in India and allows SGD Pharma to adopt Corningโ€™s Velocityยฎย Vialย technologyย platform. Combiningย SGDย Pharmaโ€™sย vial-converting expertise withย Corningโ€™s proprietaryย glass-coatingย technology, the collaboration will enhanceย vialย quality,...

Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Samsung Biologics and Pfizer announced a strategic partnership for the long-term commercial manufacturing of Pfizerโ€™s multi-product portfolio. Samsung Biologics and Pfizer entered into an initial manufacturing agreement in March 2023 for a Pfizer product. Under the terms of the new...

5 Strategies To Promote Your Dental Practice In The Digital Age

In todayโ€™s digital age, itโ€™s more important than ever for dental practices to have a strong online presence. With so many people using the internet to find and research healthcare providers, itโ€™s crucial to make sure your practice is...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป